RTI Surgical (RTI) is a global, industry-leading contract development and manufacturing organization (CDMO) serving the regenerative medicine industry. As the only regenerative medicine company that offers a differentiated portfolio of allograft and xenograft biomaterials at scale, RTI provides customers across a diverse set of market segments with leading-edge expertise, scale and flexibility across end-to-end services including design, development, regulatory support, verification and validation, manufacturing and supply chain management. Our Mission is to enhance patients' lives by creating the best clinical outcomes through innovative, high-quality medical solutions.